Phase 4 N=411 On Versus Off Pump Myocardial Revascularization Study
Coronary Artery Disease
Primary: Number of Patients With Post-operative Combined Endpoint (i.e. With One or More of the Following) — 13; 26 participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 4 N=10 Effects of Kuvan on Melatonin Secretion
Phenylketonuria (PKU)
Primary: Serum Melatonin at the End of 4 Weeks — 266.9; 205.7; 220.4; 301.2 pg/ml
Phase 4 N=87 Efficacy of Fish Oil in Lupus Patients
Systemic Lupus Erythematosus
Primary: Effect on Brachial Artery Flow Dilation by Omega-3 Versus Placebo. — 0.32; 0.33; 0.32; 0.33 cm — p=0.87
Phase 4 N=41 The Effect of Linagliptin on Mitochondrial and Endothelial Function
Type II Diabetes Mellitus
Primary: Phosphocreatine (PCR) Recovery Time After Exhaustive or up to 6 Minutes of Leg Exercise. — 0.0; 1.01 seconds — p=>0.05
Phase 4 N=34 Rituximab in Progressive Immunoglobulin A (IgA) Nephropathy
IgA Nephropathy
Primary: Change in Proteinuria at 12 Months — 3; 3; 1; 2 participants
Phase 4 N=166 Local Anesthesia Versus Saline Serum in Surgical Incision of Colorectal or Hepatic Surgery
Postoperative Pain · Surgery · Postoperative Complications
Primary: Mg of Morphine Consumption During 48 Hours Administered by Patient Controlled Analgesia System — 23; 52; 24.63; 26.78 mg
Phase 4 N=603 Parietex Progrip Study
Hernia, Inguinal
Primary: Pain Assessment During the First Three Months and at One Year After Surgery Using a Visual Analogue Scale (VAS) — 7.48; 6.76; 4.62; 5.27 units on a scale
Phase 4 N=61 Efficacity Assessment of PREVADH® in Adhesion Prevention in Gynaecologic Surgery
Uterine Fibroids · Fertility Disorders
Primary: Number of Patients With Adhesions to Uterine Scars — 12; 24 participants
Phase 4 N=58 Olux E Foam and Sorilux Foam Combination Therapy for the Maintenance of Treatment Response in Patients With Moderate Plaque Psoriasis
Psoriasis
Primary: Physician Global Assessement — 68; 80; 79 percentage of patients
Phase 4 N=25 Study Response of 13-valent Conjugate Pneumococcal Vaccine in Patients With End Stage Renal Disease
End Stage Renal Disease
Primary: Change From Baseline in Antibody Concentrations After 13-valent Conjugate Pneumococcal Vaccination in in Patients 50 Years or Older With End Stage Renal Disease on…
Phase 4 N=67 Medical Therapy Versus Radiofrequency Endometrial Ablation in the Initial Treatment of Menorrhagia
Menorrhagia
Primary: Menstrual Blood Loss (MBL) as Measured by Pictorial Blood Loss Assessment Chart (PBLAC). — 15; 0 units on a scale — p=0.003
Phase 4 N=829 Efficacy and Safety of Coumarin and Troxerutin in the Symptomatic Treatment of Chronic Venous Insufficiency
Chronic Venous Insufficiency
Primary: Mean Change (Reduction) From Baseline in Volume of Reference Leg at Week 16 — 1.13; 5.78 milliliters (mL) — p=0.531
Phase 4 N=121 Tolerability of Rivastigmine Before and After Switching From Oral Formulation to Transdermal Patch in Alzheimer's Dementia
Alzheimer's Dementia
Primary: Number of Patients With Adverse Events, Serious Adverse Events, and Death — 16; 94; 0 Participants
Phase 4 N=406 Evaluating the Control of COPD Symptoms in Patients Treated With Tiotropium Bromide 18mcg Once Daily Alone, ADOAIR 50/250mcg Twice Daily Alone or ADOAIR 50/250mcg Plus Tiotropium Bromide 18mcg
Pulmonary Disease, Chronic Obstructive
Primary: Percentage of Participants Who Were Able to Remain on the Randomized Treatment — 62.69; 66.67 Percentage of participants
Phase 4 N=278 Different LD of Ticagrelor for Antiplatelet Effect in Patients With Non-ST-segment Elevation ACS Undergoing PCI
Non ST Segment Elevation Acute Coronary Syndrome
Primary: Platelet Reactivity Index(PRI) Measured by VASP-P — 16.7; 12.2 percentage of 100